0

Red Cell Disorders Collection
 1-20 of 511 Articles
Clinical Guidelines |  3 December 2013 FREE
Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians
Amir Qaseem, MD, PhD, MHA; Linda L. Humphrey, MD, MPH; Nick Fitterman, MD; et al.
Ann Intern Med. 2013;159(11):770-779. doi:10.7326/0003-4819-159-11-201312030-00009
Reviews |  3 December 2013 FREE
Treatment of Anemia in Patients With Heart Disease: A Systematic Review
Devan Kansagara, MD, MCR; Edward Dyer, MD; Honora Englander, MD; et al.
Ann Intern Med. 2013;159(11):746-757. doi:10.7326/0003-4819-159-11-201312030-00007
Ideas and Opinions |  5 November 2013
Emphasis and Priority
G. Stuart Mendenhall, MD
Ann Intern Med. 2013;159(9):627-628. doi:10.7326/0003-4819-159-9-201311050-00009
Letters |  2 July 2013
Successful Treatment of the Postpartum Atypical Hemolytic Uremic Syndrome With Eculizumab
Stefan Zschiedrich, MD; Eric P. Prager, MD; E. Wolfgang Kuehn, MD
Ann Intern Med. 2013;159(1):76. doi:10.7326/0003-4819-159-1-201307020-00023
Editorials |  6 July 2010 FREE
Anemia Management in Chronic Kidney Disease: Bursting the Hemoglobin Bubble
Daniel E. Weiner, MD, MS; Dana C. Miskulin, MD, MS
Ann Intern Med. 2010;153(1):53-55. doi:10.7326/0003-4819-153-1-201007060-00250
Reviews |  15 April 2008
Narrative Review: Paroxysmal Nocturnal Hemoglobinuria: The Physiology of Complement-Related Hemolytic Anemia
Robert A. Brodsky, MD
Ann Intern Med. 2008;148(8):587-595. doi:10.7326/0003-4819-148-8-200804150-00003
Articles |  15 January 2008
Daily Assessment of Pain in Adults with Sickle Cell Disease
Wally R. Smith, MD; Lynne T. Penberthy, MD, MPH; Viktor E. Bovbjerg, PhD, MPH; et al.
Ann Intern Med. 2008;148(2):94-101. doi:10.7326/0003-4819-148-2-200801150-00004
Articles |  7 February 2006 FREE
Brief Communication: Successful Treatment of Pure Red-Cell Aplasia with an Anti–Interleukin-2 Receptor Antibody (Daclizumab)
Elaine M. Sloand, MD; Phillip Scheinberg, MD; Jaroslaw Maciejewski, MD; et al.
Ann Intern Med. 2006;144(3):181-185. doi:10.7326/0003-4819-144-3-200602070-00006
Articles |  16 September 2003
The Rate of Progression to Polycythemia Vera or Essential Thrombocythemia in Patients with Erythrocytosis or Thrombocytosis
Marco Ruggeri, MD; Alberto Tosetto, MD; Maurizio Frezzato, MD; et al.
Ann Intern Med. 2003;139(6):470-475. doi:10.7326/0003-4819-139-6-200309160-00009
Ideas and Opinions |  1 April 2003
Genomics and Medicine: Distraction, Incremental Progress, or the Dawn of a New Age?[dhelix]
Richard S. Cooper, MD; Bruce M. Psaty, MD, PhD
Ann Intern Med. 2003;138(7):576-580. doi:10.7326/0003-4819-138-7-200304010-00014
Supplement: The Future of Primary Care |  4 February 2003
Primary Care at a Crossroads
Jonathan Showstack, PhD, MPH; Arlyss Anderson Rothman, PhD, MHS, FNP; Susan Hassmiller, PhD, RN
Ann Intern Med. 2003;138(3):242-243. doi:10.7326/0003-4819-138-3-200302040-00031
Articles |  6 August 2002
Outcome of Pregnancy and Disease Course among Women with Aplastic Anemia Treated with Immunosuppression
André Tichelli, MD; Gérard Socié, MD, PhD; Judith Marsh, MD; et al.
Ann Intern Med. 2002;137(3):164-172. doi:10.7326/0003-4819-137-3-200208060-00008
Brief Communications |  7 May 2002
Reversibility of Cirrhosis in Patients Cured of Thalassemia by Bone Marrow Transplantation
Pietro Muretto, MD; Emanuele Angelucci, MD; Guido Lucarelli, MD
Ann Intern Med. 2002;136(9):667-672. doi:10.7326/0003-4819-136-9-200205070-00009
Brief Communications |  18 December 2001
Quinine-Associated Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome: Frequency, Clinical Features, and Long-Term Outcomes
Kiarash Kojouri, MD, MPH; Sara K. Vesely, PhD; James N. George, MD
Ann Intern Med. 2001;135(12):1047-1051. doi:10.7326/0003-4819-135-12-200112180-00008
Articles |  6 November 2001 FREE
Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus
Brian J. McMahon, MD; Peter Holck, PhD; Lisa Bulkow, MS; et al.
Ann Intern Med. 2001;135(9):759-768. doi:10.7326/0003-4819-135-9-200111060-00006
Editorials |  2 October 2001
Aplastic Anemia: Which Treatment?
Janis L. Abkowitz, MD
Ann Intern Med. 2001;135(7):524-526. doi:10.7326/0003-4819-135-7-200110020-00012
Articles |  2 October 2001
Durable Treatment-Free Remission after High-Dose Cyclophosphamide Therapy for Previously Untreated Severe Aplastic Anemia
Robert A. Brodsky, MD; Lyle L. Sensenbrenner, MD; B. Douglas Smith, MD; et al.
Ann Intern Med. 2001;135(7):477-483. doi:10.7326/0003-4819-135-7-200110020-00006
Editorials |  17 April 2001
Out of Thin Air: The Evolving Enigma of Erythropoietin and Neocytolysis
Bernard A. Harris, MD; Paul E. Epstein, MD
Ann Intern Med. 2001;134(8):710-712. doi:10.7326/0003-4819-134-8-200104170-00015
Brief Communications |  17 April 2001
Neocytolysis on Descent from Altitude: A Newly Recognized Mechanism for the Control of Red Cell Mass
Lawrence Rice, MD; Wilson Ruiz, MD; Theda Driscoll, CNT; et al.
Ann Intern Med. 2001;134(8):652-656. doi:10.7326/0003-4819-134-8-200104170-00010
Articles |  5 September 2000
The Effect of HFE Genotypes on Measurements of Iron Overload in Patients Attending a Health Appraisal Clinic
Ernest Beutler, MD; Vincent Felitti, MD; Terri Gelbart, BS; et al.
Ann Intern Med. 2000;133(5):329-337. doi:10.7326/0003-4819-133-5-200009050-00008
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)